Achieve Successful Cell Culture Scale-Up
with Allegro™ Single-use Stirred Tank Bioreactors
Discover how Allegro STR single-use bioreactors can help improve your bioprocess. Download our poster on “Engineering Characterization of the Allegro Stirred Tank Reactors for Successful Cell Culture Scale-Up”.
Ideal for monoclonal antibody (mAb) production, recombinant protein manufacturing, viral vaccine production, and stem cell production.
The Allegro STR bioreactor family from Pall Life Sciences provides consistent and scalable cell culture performance from benchtop to production-scale cGMP manufacturing. This series of single-use bioreactors combines Pall’s bioprocess engineering expertise, cell culture know-how, and steadfast commitment to quality. A unique square design provides significant benefits over cylindrical cell culture bioreactors.
Typical applications include:
- Mammalian suspension cell culture, e.g., Chinese Hamster Ovary (CHO) and HEK293 cells
- Insect cell culture, e.g. Sf9 cells
- Suspension cells in batch, fed-batch, perfusion mode
- Adherent cell growth on microcarriers, e.g. vero
Key advantages of Allegro STR single-use stirred tank bioreactors:
- Mass transfer (high kLa and CO2 stripping efficiency) with short mixing times (< 30 seconds)
- Simple installation and intuitive operation
- Compact cleanroom footprint; 2000 L bioreactor fits under 3 meters
- Optimized temperature control
Backed by Pall Accelerator Development Services
Our global team of experiences scientists and engineers is available to provide a range of consultation services and technical support to meet your specialized project needs, including cell culture process development, process scale-up, tech transfer, instrument installation and qualification, and customizd on-site training.
About Pall Life Sciences
Pall Life Sciences, a division of Pall Corporation (a Danaher company), delivers total product and service solutions to global researchers, developers and manufacturers of large and small molecule drugs. The unmatched portfolio of traditional and single-use products is backed by custom service support and is both scalable and easily integrated to support processes from R&D through to commercial phases of production, including formulation/filling. As one of the first companies to spearhead the continuous bioprocessing movement, Pall has remained focused on delivering innovative semi- and fully continuous solutions. With the goal of continuously improving bioprocesses for a safer, healthier future.
Recognized Industry Leadership
Pall Corporation, 20 Walkup Dr, Westborough, MA 01581, USA | Tel: 1-516-484-3600 | www.pall.com
© 2017 Pall Corporation. Pall and the Pall logo are registered trademarks of Pall Corporation.